Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 5, 2001, Pages 1591-1594

  Nicoletti, F ^a   Di Marco, R ^a   Sacerdote, P ^a   Meroni, P ^a   Mangano, K ^a   Edwards III, C ^a   Bartorelli, A ^a   Bendtzen, K ^a   Panerai, A ^a  

^a NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; IMMUNOMODULATING AGENT; MULTIFUNCTIONAL PROTEIN 14; PROTEIN MFP 14; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; EXPERIMENTAL INFECTION; FEMALE; LETHALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; FEMALE; HEAT-SHOCK PROTEINS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PROTEINS; RIBONUCLEASES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035038580     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.5.1591-1594.2001     Document Type: Article

References (26)

1. A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxaemia in mice
2. Protection against endotoxin shock by tumor necrosis factor receptor immunoadhesin
3. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence
4. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction
5. Interleukin-1, interleukin-6 and tumour necrosis factor in infection, inflammation and immunity
6. The primary structure of UK-114 tumor antigen
7. cDNA cloning and Escherichia coli expression of MFP14 tumor antigen
8. A new kinetic single-stage Limulus amoebocyte lysate method for the detection of of endotoxin in water and plasma
9. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
10. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice
11. The role of IFN-γ in the pathology of experimental endotoxemia
12. Interleukin-10 protects mice from lethal endotoxemia
13. Characterization, purification and cDNA cloning of rat perchloric-acid-soluble-23-kDa protein present in liver and kidney
14. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock
15. Molecular and functional properties of a calpain activator protein specific for μ-isoforms
16. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: Correlation with down-modulation of TNF-α, IFN-γ and IL-12 production
17. Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13
18. Endotoxin-induced lethality in mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10
19. Interleukin-1 receptor antagonist reduces mortality from septic shock
20. Isolation and characterization of a novel perchloric acid-soluble protein inhibiting cell-free protein synthesis
21. Chronic administration of UK-114, a multifunctional emerging protein, modulates the Th1/Th2 cytokine pattern and experimental autoimmune diseases
22. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus
23. Isolation and characterization of a 14.5-kDa trichloroacetic-acid-soluble translational inhibitor protein from human monocytes that is upregulated upon cellular differentiation
24. A bidirectional promoter connects the p14.5 gene to the gene for RNase P and RNase MRP protein subunit hPOP1
25. Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor
26. The effects of a monoclonal antibody to interferon-γ on experimental autoimmune thyroiditis: Prevention of disease and decrease of EAT-specific T cells